To assess whether CD32-CR triggering might result in direct anti-tumor activity, MDA-MB-468LUC (luciferase-expressing) cells were incubated in the presence or absence of CD32-CR T cells, whereas NT T cells were used as negative controls. This evidence concerns the gene FCGR2B and neoplasm.